re: sales of relenza fianlly found confirmation re sales of relenza over the quarter
http://www.bloomberg.com/apps/news?pid=10000085&sid=aS1YwybiZb.c&refer=europe
"Glaxo said sales of Relenza rose 70 percent to 5.2 million pounds. "
That is, about 12.27 million Aus dollars, or at royalties of 7% about $860,000 to Biota.
But only for a quarter and off a very low base of production.
gsk downplaying news, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)